Jul. 17, 2023
McKesson’s $141M settlement with investors is approved
McKesson, the nation’s largest wholesale distributor of prescription drugs, was found to be one step removed from being an active participant in a national price-fixing scheme, which involved pharmaceutical giants.
A federal judge granted final approval Friday for a $141 million settlement between McKesson Corp. and its investors to resolve accusations that the pharmaceutical company misrepresented that it increased drug prices because of supply disruptions when in reality it was benefiting from a nationwide generic medicine price-fixing conspiracy.
According to filings, the settlement recovers approximately 20% of the estimated reasonably recoverab...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In